Anton Melnyk
Yuriy Fedkovych Chernivtsi National University(UA)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, PI3K/AKT/mTOR signaling in cancer, Conducting polymers and applications, Advanced Breast Cancer Therapies, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology(2008)493 cited
- → Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer(2011)193 cited
- → Gemcitabine, Cisplatin, and Sunitinib for Metastatic Urothelial Carcinoma and as Preoperative Therapy for Muscle-Invasive Bladder Cancer(2012)85 cited
- → Sub-ns triplet state formation by non-geminate recombination in PSBTBT:PC70BM and PCPDTBT:PC60BM organic solar cells(2015)70 cited
- → Polaron spin dynamics in high-mobility polymeric semiconductors(2019)66 cited
- → Generic Model for Lamellar Self-Assembly in Conjugated Polymers: Linking Mesoscopic Morphology and Charge Transport in P3HT(2019)61 cited
- → Macroscopic Structural Compositions of π-Conjugated Polymers: Combined Insights from Solid-State NMR and Molecular Dynamics Simulations(2017)40 cited
- → Phase I Basket Study of Taselisib, an Isoform-Selective PI3K Inhibitor, in Patients with PIK3CA -Mutant Cancers(2020)38 cited
- → Adult Hemolytic-Uremic Syndrome(1995)37 cited
- → Phase II study of gemcitabine, cisplatin, and sunitinib (S) in patients with advanced urothelial carcinoma (UC).(2012)23 cited